Lin, C., Chen, M., Chai, J., Jani, J., Kolli, S., Schrum, D., … Koenig, E. (2025). Remote multi-vital sign monitoring allows earlier detection of cytokine release syndrome after bispecific T cell engager and chimeric antigen receptor T cell therapies. In Blood (Vol. 146, pp. 1075–1075). American Society of Hematology. https://doi.org/10.1182/blood-2025-1075

Lin, Chenyu, Melinda Chen, Jingchen Chai, Janvi Jani, Sashi Kolli, Daniel Schrum, Erin Eberwein, et al. “Remote multi-vital sign monitoring allows earlier detection of cytokine release syndrome after bispecific T cell engager and chimeric antigen receptor T cell therapies.” In Blood, 146:1075–1075. American Society of Hematology, 2025. https://doi.org/10.1182/blood-2025-1075.

Lin C, Chen M, Chai J, Jani J, Kolli S, Schrum D, et al. Remote multi-vital sign monitoring allows earlier detection of cytokine release syndrome after bispecific T cell engager and chimeric antigen receptor T cell therapies. In: Blood. American Society of Hematology; 2025. p. 1075–1075.

Lin, Chenyu, et al. “Remote multi-vital sign monitoring allows earlier detection of cytokine release syndrome after bispecific T cell engager and chimeric antigen receptor T cell therapies.” Blood, vol. 146, no. Supplement 1, American Society of Hematology, 2025, pp. 1075–1075. Crossref, doi:10.1182/blood-2025-1075.

Lin C, Chen M, Chai J, Jani J, Kolli S, Schrum D, Eberwein E, Cash C, Tichon J, Bush A, Hill L, Misuraca J, McKinney M, Long G, Gasparetto C, Choi T, Ramalingam S, Kirby S, LeBlanc T, Sitlinger A, Sung A, Torres R, Rutledge K, Ream M, Gannon J, Kang Y, Sarantopoulos S, Horwitz M, Siegelman J, Phillips R, Jung S-H, Koenig E. Remote multi-vital sign monitoring allows earlier detection of cytokine release syndrome after bispecific T cell engager and chimeric antigen receptor T cell therapies. Blood. American Society of Hematology; 2025. p. 1075–1075.